HIV treatment cascade in tuberculosis patients

Current Opinion in HIV and AIDS
Richard J LessellsPeter Godfrey-Faussett

Abstract

Globally, the number of deaths associated with tuberculosis (TB) and HIV coinfection remains unacceptably high. We review the evidence around the impact of strengthening the HIV treatment cascade in TB patients and explore recent findings about how best to deliver integrated TB/HIV services. There is clear evidence that the timely provision of antiretroviral therapy (ART) reduces mortality in TB/HIV coinfected adults. Despite this, globally in 2013, only around a third of known HIV-positive TB cases were treated with ART. Although there is some recent evidence exploring the barriers to achieve high coverage of HIV testing and ART initiation in TB patients, our understanding of which factors are most important and how best to address these within different health systems remains incomplete. There are some examples of good practice in the delivery of integrated TB/HIV services to improve the HIV treatment cascade. However, evidence of the impact of such strategies is of relatively low quality for informing integrated TB/HIV programming more broadly. In most settings, there remain barriers to higher-level organizational and functional integration. There remains a need for commitment to patient-centred integrated TB/HIV care in cou...Continue Reading

References

Feb 26, 2010·The New England Journal of Medicine·Salim S Abdool KarimQuarraisha Abdool Karim
Oct 21, 2011·The New England Journal of Medicine·François-Xavier BlancUNKNOWN CAMELIA (ANRS 1295–CIPRA KH001) Study Team
Oct 21, 2011·The New England Journal of Medicine·Diane V HavlirUNKNOWN AIDS Clinical Trials Group Study A5221
Oct 21, 2011·The New England Journal of Medicine·Salim S Abdool KarimQuarraisha Abdool Karim
Jan 1, 2013·Health Policy and Planning·Jennifer UyeiSally Guttmacher
Jun 19, 2013·Journal of the International Association of Providers of AIDS Care·Katherine Frasca, Jennifer Cohn
Jul 6, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M R PatelA Van Rie
Oct 5, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Annelies Van RieFrieda Behets
Dec 11, 2013·The Lancet. Respiratory Medicine·Ajay M V KumarAnthony D Harries
Jan 17, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N PadayatchiG Friedland
Mar 25, 2014·Lancet·Nick HerbertAlimuddin I Zumla
Mar 29, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J UyeiS Guttmacher
Apr 25, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olivier MarcyUNKNOWN CAMELIA (ANRS 1295-CIPRA KH001) Study Team
May 14, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Richard KaplanRobin Wood
Jun 6, 2014·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·R KaplanN Beyers
Jun 7, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M R PatelA Van Rie
Jun 10, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hai-Yin JiangBing Ruan
Jul 22, 2014·Social Science & Medicine·Joshua Amo-AdjeiKofi Awusabo-Asare
Jul 30, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Heidi M SoetersAnnelies Van Rie
Aug 20, 2014·Infectious Diseases of Poverty·Ahmed ArshadZulfiqar A Bhutta
Sep 14, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S GuptaB Samb
Nov 12, 2014·AIDS·Amrita DaftaryNesri Padayatchi
Jan 13, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M LovedayN Padayatchi
Mar 27, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Q M TrinhB J Marais
Sep 25, 2015·Public Health Action·P OwitiA Gardner
Jan 21, 2016·International Journal of Mycobacteriology·Stefanie SeelingTimo Ulrichs

❮ Previous
Next ❯

Citations

Mar 24, 2016·BMC Infectious Diseases·M Gabriela M GomesS Bertel Squire
Oct 7, 2017·Global Public Health·Prince Justin AnkuAkwasi Kumi-Kyereme
Oct 20, 2018·AIDS and Behavior·Mary HawkUNKNOWN AIDS United Retention in Care Intervention Team
Apr 17, 2018·Open Forum Infectious Diseases·Marcos C SchechterRussell R Kempker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.